Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

EXPLAINED: Moderna stock sinks following vaccine data leak | Rare Historical Photos

Moderna (MRNA) shares slipped sharply late on Thursday after the biotech firm’s cancer-vaccine trial results circulated ahead of their scheduled presentation. Oncology Central reportedly published the leaked data before removing its article, but screenshots had already spread across social media.

Despite the recent decline, Moderna stock has been a blockbuster investment in 2026, currently trading at roughly 6x its price at the start of this year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.